Search

everythinglearnresearchcommunity

for

Search:↓

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Agaricus bisporus derived β-Glucan could be an effective cervical cancer treatment with antimicrobial and antioxidant properties.

Skin stem cells are crucial for maintaining and repairing skin, with potential for treating skin disorders and improving wound healing.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Stem cell plasticity is crucial for wound healing but can also contribute to cancer development.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

Certain Dibenzo derivatives may help treat prostate cancer.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Epigenetic changes control how adult stem cells work and can lead to diseases like cancer if they go wrong.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

ΔNp63α helps control a protein that stops cancer cells from spreading.